North America Market Research Reports & Industry Analysis

Publications found: 97,050
Sort by:

Coal Liquefaction Industry in United States

US$ 350.00

... . Aruvian's R'search’s report on the Coal Liquefaction Industry in the United States is a complete coverage report which focuses on the basics of coal liquefaction, its history, challenges and barriers ...

June 2012 111 pages

Biofuel Industry in the United States

US$ 325.00

... from corn grain and biodiesel are the only biofuels produced in the United States on an industrial scale. Most of the four billion gallons of ... an in-depth coverage for this industry in the United States in its latest research report – Biofuel Industry in the United States. This 100 page report looks at the ...

June 2012 145 pages

Profiling the US Petroleum Refining Industry

US$ 350.00

... low quality crude oils. Aruvian Research’s report – Profiling the US Petroleum Refining Industry – analyzes the US petroleum refining industry starting from the basics. The report ...

June 2012 100 pages

Analyzing the Energy Industry in United States

US$ 450.00

... as supply strategies globally. Aruvian's R'search’s report – Analyzing the Energy Industry in United States - analyzes the scope of American energy production from varied traditional sources as well as the ...

June 2012 700 pages

Analyzing the Nuclear Power Industry in the US

US$ 400.00

The United States is the world's largest supplier of commercial nuclear power. In recent years, there has been a renewed interest in nuclear power in the US. This has been facilitated in part ...

June 2012 200 pages

Analyzing Light-Duty Hybrid-Electric Vehicles in the US

US$ 400.00

... electric vehicles are finally being sold commercially by manufacturers. The demand for light-duty hybrid-electric vehicles in the United States ... . Aruvians Rsearch analyzes the Light Duty Hybrid Electric vehicles market in the US in its research offering Analyzing Light Duty Hybrid Electric Vehicles in the US. ...

June 2012 85 pages

Analyzing the Market for Refined Petroleum Products in the US

US$ 350.00

The United States is the largest, most sophisticated producer of refined petroleum products in the world, with nearly 20 million ... , amongst others. Aruvians Rsearch analyzes the refined petroleum products market in the US in its research offering Analyzing the Market for Refined Petroleum Products in the US. ...

June 2012 105 pages

Analyzing Geothermal Power in North & South America

US$ 550.00

... analyzes the Geothermal Power in North & South America in its latest research offering Analyzing Geothermal Power in North & South America. The report is a comprehensive coverage of the geothermal industry in many countries in both North and South America ...

June 2012 275 pages

Analyzing Geothermal Power in Costa Rica

US$ 400.00

... Geothermal Power in Costa Rica in its latest research offering Analyzing Geothermal Power in Costa Rica. The report is a comprehensive coverage of the geothermal industry in the region as well as in Costa Rica. The report begins with an introduction to geothermal power. We analyze ...

June 2012 180 pages

Analyzing Geothermal Power in El Salvador

US$ 400.00

... Geothermal Power in El Salvador in its latest research offering Analyzing Geothermal Power in El Salvador. The report is a comprehensive coverage of the geothermal industry in the region as well as in El Salvador. The report begins with an introduction to geothermal power. We analyze ...

June 2012 180 pages

Analyzing Geothermal Power in Guatemala

US$ 400.00

... Geothermal Power in Guatemala in its latest research offering Analyzing Geothermal Power in Guatemala. The report is a comprehensive coverage of the geothermal industry in the region as well as in Guatemala. The report begins with an introduction to geothermal power. We analyze ...

June 2012 180 pages

Analyzing Geothermal Power in Mexico

US$ 400.00

... Geothermal Power in Mexico in its latest research offering Analyzing Geothermal Power in Mexico. The report is a comprehensive coverage of the geothermal industry in the region as well as in Mexico. The report begins with an introduction to geothermal power. We analyze ...

June 2012 185 pages

Analyzing Geothermal Power in Nicaragua

US$ 400.00

... Geothermal Power in Nicaragua in its latest research offering Analyzing Geothermal Power in Nicaragua. The report is a comprehensive coverage of the geothermal industry in the region as well as in Nicaragua. The report begins with an introduction to geothermal power. We analyze ...

June 2012 180 pages

Analyzing Geothermal Power in the US

US$ 400.00

... the powerful combination of high energy prices and growing state government support. The United States Department of Energy Geothermal Technologies Program ... of development. Aruvians Rsearch analyzes the Geothermal Power in the US in its latest research offering Analyzing Geothermal Power in the US. The report ...

June 2012 195 pages

Booming CCTV Market in North America Forecast to 2014

US$ 900.00

In North America, the CCTV market has already witnessed an exponential growth, and is still expanding remarkably. The video surveillance cameras are extensively used at public places. Due to increasin...

June 2012 43 pages

Biogen: Teriflunomide Does Not TOWER Over BG-12!

US$ 90.00

Top-line data from PhIII trial, TOWER of Sanofi’s Aubagio (teriflunomide, R, RRMS, PDUFA: 3Q12) reaffirms our take on BG-12 (Dimethyl fumerate, R, Est. ... details, please read our report released on June 1st , 2012 on Biogen (BIIB), titled “Teriflunomide Does Not TOWER Over BG-12”

May 2012 4 pages

Onyx Pharma - ASCO ’12: Kyprolis’ Data enough to obtain an ‘Accelerate Approval’?

US$ 90.00

... read our report released on May 31st, 2012 on ONXX, titled “ASCO ’12: Kyprolis’ Data enough to obtain an ‘Accelerate Approval’?”

May 2012 4 pages

VERTEX PHARMA - KALYDECO + VX-809 Analysis – PhIII Should be Successful in CF patients with Homozygous ΔF508 if….!

US$ 90.00

Vertex (VRTX) evoked an uproar when it corrected the data of its KLAYDECO/VX- ... detail, please read our report released on 31th May, 2012 on Vertex titled “KALYDECO + VX-809 Analysis – PhIII Should be Successful in CF patients with Homozygous ...

May 2012 3 pages

VIVUS - Which one First to the Market – Qnexa/Lorcaserin or both?

US$ 140.00

... , please read our report released on May 29, 2012 on VVUS, titled “Which one First to the Market – Qnexa/Lorcaserin or both?”

May 2012 7 pages

AMGEN: Innovation + Emerging Market – A Balanced Approach!

US$ 140.00

... boosted Amgen’s (AMGN) pipeline, while Mustafa Nevzat pharma (MN pharma, pvt., Turkey) is a strategic move to increase its presence in the growing emerging/ international markets ... read our report released on May 29th, 2012 on AMGN, titled “Innovation + Emerging Market – A Balanced Approach”

May 2012 7 pages

REGENERON - Diversified Pipeline can Buffer the Setback

US$ 140.00

Despite the setback in the pipeline – negative recommendation from FDA advisory committee on ... franchise should be able to buffer some setbacks in the pipeline. The FDA advisory panel voted 11-0 against approval of the ... , released on May 14, 2012 on REGN, titled “Diversified Pipeline can Buffer the Setback”.

May 2012 6 pages

Halozyme – “HyQvia’s Delay – Percolation to Other Drugs in the Pipeline?”

US$ 140.00

... details, please read our report released on 9th May, 2012 on Halozyme titled “HyQvia’s Delay – Percolation to Other Drugs in the Pipeline?”

May 2012 6 pages

VERTEX PHARMA - KALYDECO + VX-809/VX-661 (CF), INCIVEK (HCV) + Pipeline –Value Loaded!

US$ 90.00

Vertex (VRTX) released positive PhII data from KALYDECO in combination with VX-809 for CF pts with delF508 mutation. Low ... detail, please read our report released on 8th May, 2012 on Vertex titled “KALYDECO + VX-809/VX-661 (CF), INCIVEK (HCV) + Pipeline –Value Loaded ...

May 2012 6 pages

GILEAD - After HIV -Poised to Deliver the Best Anti-Viral Treatment Options for HCV!

US$ 90.00

Gilead’s supremacy in the HIV space in 2012-18 should remain intact with the successful launch of ... , please read our report released on 3rd May, 2012 on Gilead titled “After HIV -Poised to Deliver the Best Anti-Viral Treatment Options for HCV!”

May 2012 9 pages

INCYTE: JAKAFI / JAKAVI to Drive Sustainable Profitability

US$ 140.00

Incyte (INCY) reported net revenues of $19.3m of the only approved drug for Myelofribrosis (MF), JAKAFI / JAKAVI (ruxolitinib, JAK 1/2 inhibitor, PhII/III in PV/ET; partnered with Novartis for ... , please read our report released on May 2, 2012 on INCY, titled “JAKAFI / JAKAVI to Drive Sustainable Profitability”

May 2012 3 pages

Analyzing the Market for Pigments in US

US$ 400.00

... few of the top players in the market. Aruvians Rsearch analyzes the Pigments market in the US in its research offering Analyzing the Market for Pigments in US. The report is a complete analysis ...

May 2012 90 pages

Analyzing the Market for Industrial Gases in Canada

US$ 400.00

... analyzes the industrial gas industry in Canada in its research report Analyzing the Market for Industrial Gases in Canada. The report is a complete coverage of this industry as we analyze the market through an industry overview, an analysis of the industry ...

May 2012 65 pages

Analyzing the Battery Market in US

US$ 400.00

... five years. The United States is the single biggest market in the world for batteries with a market size of $5 billion annually. The US industrial market is estimated to be $600 million ...

May 2012 100 pages

Analyzing the Market for Pulp & Paper Chemicals in the US

US$ 400.00

... environmentally-friendly profiles. Aruvians Rsearch analyzes the Pulp & Paper Chemicals market in the US in its research offering Analyzing the Market for Pulp & Paper Chemicals in the US. The ...

May 2012 115 pages

US Nutraceuticals Market Analysis

US$ 1,000.00

update

May 2012 105 pages

REGENERON - A Myriad of Opportunities - EYLEA (AMD, CRVO) + ZALTRAP (mCRC) + ARCALYST (Gout)

US$ 140.00

... , please read our report, released on May 1, 2012 on REGN, titled “A Myriad of Opportunities – EYLEA (AMD, CRVO) + ZALTRAP (mCRC) + ARCALYST (Gout ...

April 2012 6 pages

VERTEX PHARMA - KALYDECO Uptake Balances INCIVEK Disappointment - 2012 Guidance Achievable!

US$ 140.00

Vertex (VRTX) 1Q12 earnings highlighted robust KALYDECO sales (L in US, CF pts with ... also plans to begin three additional pivotal studies of KALYDECO to target CF pts with R117H mutation and in ... on 1st May, 2012 on Vertex titled “KALYDECO Uptake Balances INCIVEK Disappointment - 2012 Guidance Achievable!”

April 2012 4 pages

CELGENE – Revlimid Sales Disappoints, but Long Term Prospects Intact!

US$ 90.00

Though Q1’12 earnings were disappointing (flat growth of Revlimid), we expect Celgene (CELG) should able to meet its FY12 guidance (Total rev.: $5.4-$5.6b ... read our report released on 27th April, 2012 on CELG titled, “Revlimid Sales Disappoints, but Long Term Prospects Intact!”

April 2012 4 pages

ALEXION: Soliris’ Label Expansion & Diversification to Perk ALXN Up!

US$ 140.00

... Hemolytic Uremic Syndrome (aHUS) indication, and label expansion in other rare and high unmet need indications of Soliris; we expect the growth trajectory continues ... , please read our report released on April 25, 2012 on ALXN, titled “Soliris’ Label Expansion & Diversification to Perk ALXN Up!”

April 2012 5 pages

Ardea Biosciences – “Astra Acquires Ardea – Lesinurad’s Opportunity Expands!”

US$ 90.00

... of Ardea Biosciences (RDEA) by AstraZeneca (AZN) for $32/s or ~$1.26b is the second deal in this month in the gout space, after Takeda (TYO: 4502) acquired privately ...

April 2012 2 pages

2012 US Hemostasis Diagnostics Market Outlook: Growth Opportunities and Strategies

US$ 6,800.00

Report Highlights Comprehensive 424-page analysis of the US hemostasis market. Major issues pertaining to the US hemostasis laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Ten-year volume and ...

April 2012 424 pages

2012 US Hematology and Flow Cytometry Market Outlook: Growth Opportunities and Strategies

US$ 7,600.00

... - and ten-year volume and sales forecasts for major hematology and flow cytometry tests, performed in US hospitals, commercial laboratories, physician offices and ambulatory care centers. Annual placements and installed base estimates for major automated and semiautomated hematology analyzers and ...

April 2012 275 pages

2012 US Flow Cytometry Market Outlook: Growth Opportunities and Strategies

US$ 4,720.00

This report presents a comprehensive analysis of the US flow cytometry market, including: Major issues pertaining to the US flow cytometry practice, as well as key economic, ... with significant market impact during the next five years. Five-year volume and sales forecasts for major flow cytometry tests ...

April 2012 174 pages

INCYTE: Cheers for INCY - JAKAVI Receives CHMP Nod!

US$ 90.00

Incyte/ Novartis’ JAKAVI (ruxolitinib, JAK 1/2 inhibitor, Registered for MF; PhII ... triggers $40m milestone payment from Novartis (Ex-US rights), and INCY will received a second payment of $60m upon an achievement ... our report released on April 20, 2012 on INCY, titled “Cheers for INCY - JAKAVI Receives CHMP Nod!”

April 2012 2 pages

2012 US Clinical Chemistry and Immunodiagnostics Market Outlook: Growth Opportunities and Strategies

US$ 8,560.00

... chemistry and immunodiagnostics markets, including: Major issues pertaining to the US clinical chemistry and immunodiagnostic laboratory practice, as well as key economic, regulatory, demographic, ... market impact during the next ten years. Five- and ten-year volume and sales forecasts for over 100 clinical ...

April 2012 600 pages

Strategic Implications of Innovative, Technological and Market Trends for the US Diagnostics Market

US$ 3,880.00

... accommodate uncertainties ahead. The report evaluates emerging markets and technologies that may present unexpected threats or offer opportunities; identifies key strategic decisions that will have to be made in the future; and enhances corporate ability to develop ...

April 2012 135 pages

Merck - Celltrion filed first mAB Biosimilar in Europe: Remicade Challenged

US$ 90.00

Celltrion filed infliximab biosimilar (CT-P13) in Europe and was accepted for review by EMA. It is the first biosimilar mAb to be filed for approval in Europe. The patent ... Celltrion conducted PhI and PhIII clinical trials with the duration of 12 months in more than 850 patients. It has already filed Infliximab ...

April 2012 1 pages

Trinidad & Tobago LNG Markets to 2020 - Analysis and Forecasts of Terminal wise Capacity and Associated Contracts, LNG Trade movements and Prices

US$ 1,999.00

The new comprehensive report on Trinidad & Tobago LNG industry from LNGReports provides complete analysis, data and forecasts of the industry from 2000 to 2020. Annual information on LNG trade, ca...

April 2012 140 pages

Bahamas LNG Markets to 2020 - Analysis and Forecasts of Terminal wise Capacity and Associated Contracts, LNG Trade movements and Prices

US$ 1,999.00

The new comprehensive report on Bahamas LNG industry from LNGReports provides complete analysis, data and forecasts of the industry from 2000 to 2020. Annual information on LNG trade, capacity, export...

April 2012 140 pages

Canada LNG Markets to 2020 - Analysis and Forecasts of Terminal wise Capacity and Associated Contracts, LNG Trade movements and Prices

US$ 1,999.00

The new comprehensive report on Canada LNG industry from LNGReports provides complete analysis, data and forecasts of the industry from 2000 to 2020. Annual information on LNG trade, capacity, exports...

April 2012 140 pages

Dominican Republic LNG Markets to 2020 - Analysis and Forecasts of Terminal wise Capacity and Associated Contracts, LNG Trade movements and Prices

US$ 1,999.00

The new comprehensive report on Dominican Republic LNG industry from LNGReports provides complete analysis, data and forecasts of the industry from 2000 to 2020. Annual information on LNG trade, capac...

April 2012 140 pages

Jamaica LNG Markets to 2020 - Analysis and Forecasts of Terminal wise Capacity and Associated Contracts, LNG Trade movements and Prices

US$ 1,999.00

The new comprehensive report on Jamaica LNG industry from LNGReports provides complete analysis, data and forecasts of the industry from 2000 to 2020. Annual information on LNG trade, capacity, export...

April 2012 140 pages

Mexico LNG Markets to 2020 - Analysis and Forecasts of Terminal wise Capacity and Associated Contracts, LNG Trade movements and Prices

US$ 1,999.00

The new comprehensive report on Mexico LNG industry from LNGReports provides complete analysis, data and forecasts of the industry from 2000 to 2020. Annual information on LNG trade, capacity, exports...

April 2012 140 pages

Puerto Rico LNG Markets to 2020 - Analysis and Forecasts of Terminal wise Capacity and Associated Contracts, LNG Trade movements and Prices

US$ 1,999.00

The new comprehensive report on Puerto Rico LNG industry from LNGReports provides complete analysis, data and forecasts of the industry from 2000 to 2020. Annual information on LNG trade, capacity, ex...

April 2012 140 pages

United States LNG Markets to 2020 - Analysis and Forecasts of Terminal wise Capacity and Associated Contracts, LNG Trade movements and Prices

US$ 1,999.00

The new comprehensive report on United States LNG industry from LNGReports provides complete analysis, data and forecasts of the industry from 2000 to 2020. Annual information on LNG trade, capacity,...

April 2012 140 pages

Filters

Search

Categories

4,016
3,705
2,886
2,530
2,008
1,590
1,200
1,066
1,056
1,005
871
857
778
738
603
553
550
489
473
437
416
372
348
341
306
275
270
270
264
258
256
200
186
184
173
142
114
105
103
91
87
80
79
74
73
62
60
59
57
52
52
49
47
46
44
41
40
36
35
35
33
31
31
29
28
26
25
25
24
22
22
21
20
20
19
17
16
15
15
14
12
12
11
11
11
11
10
10
10
10
9
9
9
9
9
8
8
8
8
8
7
7
7
7
7
6
6
6
6
6
5
5
5
5
5
5
4
4
4
4
4
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
7
6
5
1
8
2
2
1
1
5
4
2
12
2
16
1
1
8
1
1
74
32
2
2
24
3
36
39
3
1
5
11
7
6
6
6
6
5
4
4
4
3
3
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
434
6
24
2
27
7
3
8
2
1
8
1
8
74
16
24
3
1
8
7
1
2,760
2
1
8
5
19
14
12
11
11
10
9
9
8
8
7
6
6
5
4
4
4
4
4
4
3
3
2
2
2
2
1
1
1
4
3
2
4
7
5
4
3
2
2
2
2
2
1
8
1
1
15
3
9
1
5
6
4
3
1
7
3
2
1
1
3
5
3
1
1
15
5
8
103
5
7
2
2
1
1
3
3
1
5
3
2
3,972
513
481
405
331
269
206
196
187
117
110
80
79
64
61
55
52
51
50
46
45
44
42
39
39
33
29
27
27
24
21
16
16
12
12
12
11
11
10
10
10
9
9
9
9
9
9
8
8
8
8
8
8
8
7
7
7
7
7
7
6
6
6
6
6
6
6
5
5
5
5
5
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
4
1
7
10
4
3
3
3
2
2
1
1
2
107
9
2
5
13
4
12
3
120
5
4
9
7
5
4
3
3
179
86
10
3
4
3
3
2
1
2
4
1
11
4
1
14
10
8
6
3
2
1
1
1
58
13
671
144
140
78
73
65
61
42
38
37
36
35
34
27
24
23
17
16
16
15
14
12
11
10
10
7
7
5
5
4
4
4
3
3
1
1
10
8
2
70
1
1
9
6
2
2
6
17
1
1
2
108
3
2
8
6
5
4
4
1
4
24
1
8
6
1
1
3
2
1
2
7
2
4
6
4
1
1
8
3
2
1
2
2
9
63
258
4
1
3
1
5
1
14
40
8
55
2
2
3
3
7
3
114
29
5
2
9,026
15
3
48
245
83
2
101
1
4
22
39
446
16
24
655
26
145
171
29
80
4
4
44
26
209
4
50
46
28
17
7
1
19
7
1
1
1
16
72
4
5
2
98
12

Publishers

15,092
13,573
7,070
881
236
126
120
106
19
14
6,959
1,146
1,034
4
234
117
160
3
12
32
2
646
7,395
93
1
4,194
391
5,213
1
11
1
10,002
53
2
1
2
2
6
10
8
618
2
3
5
18
57
4,997
1
9
1,519
2
175
2
7
5
96
417
2
224
2
180
51
196
13
5,936
422
1,029
2
2
15
4
19
6
49
741
27
4
11
125
17
158
3,899
2
217
8
53
13
161
158
2
17
17
27
27
80
49
154
6
3

Regions

11,703
4,264
1,040
887
858
830
822
822
787
465
412
358
348
311
211
80
44
43
43
15
13
6
3
1
1
1
1
751
20,260
301
351
2
1
51,015

Price

—

Date

—

Pages

—

Offers

417
1